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elationship Between Stress-Induced
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easured by Coronary Calcium Tomography
aniel S. Berman, MD, FACC,*† Nathan D. Wong, PHD, FACC,‡ Heidi Gransar, MS,*†
omalisa Miranda-Peats, MPH,*† John Dahlbeck, BS,*† Sean W. Hayes, MD,*†
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ory Hachamovitch, MD, FACC,§ Leslee Shaw, PHD,*† Alan Rozanski, MD, FACC*†
os Angeles and Irvine, California
OBJECTIVES We assessed the relationship between stress-induced myocardial ischemia on myocardial
perfusion single-photon emission computed tomography (MPS) and magnitude of coronary
artery calcification (CAC) by X-ray tomography in patients undergoing both tests.
BACKGROUND There has been little evaluation regarding the relationship between CAC and inducible
ischemia or parameters that might modify this relationship.
METHODS A total of 1,195 patients without known coronary disease, 51% asymptomatic, underwent
stress MPS and CAC tomography within 7.2  44.8 days. The frequency of ischemia by
MPS was compared to the magnitude of CAC abnormality.
RESULTS Among 76 patients with ischemic MPS, the CAC scores were0 in 95%,100 in 88%, and
400 in 68%. Of 1,119 normal MPS patients, CAC scores were 0, 100, and 400 in
78%, 56%, and 31%, respectively. The frequency of ischemic MPS was 2% with CAC
scores 100 and increased progressively with CAC 100 (p for trend 0.0001). Patients
with symptoms with CAC scores 400 had increased likelihood of MPS ischemia versus
those without symptoms (p  0.025). Absolute rather than percentile CAC score was the
most potent predictor of MPS ischemia by multivariable analysis. Importantly, 56% of
patients with normal MPS had CAC scores 100.
CONCLUSIONS Ischemic MPS is associated with a high likelihood of subclinical atherosclerosis by CAC, but
is rarely seen for CAC scores 100. In most patients, low CAC scores appear to obviate the
need for subsequent noninvasive testing. Normal MPS patients, however, frequently have
extensive atherosclerosis by CAC criteria. These findings imply a potential role for applying
CAC screening after MPS among patients manifesting normal MPS. (J Am Coll Cardiol
2004;44:923–30) © 2004 by the American College of Cardiology Foundationd
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en increasing body of literature demonstrates that measure-
ent of coronary artery calcification (CAC) by X-ray
omputed tomography (CT), using either electron beam
omputed tomography (EBCT) or multislice spiral com-
uted tomograpy (MSCT), represents a potent means for
mproving the diagnostic assessment and risk stratification
f patients with suspected coronary artery disease (CAD)
1–10). Hence, the applications of this newer technology
ay overlap some of the clinical applications associated with
oninvasive stress tests. For instance, for nearly three
ecades, stress myocardial perfusion single-photon emission
omputed tomography (MPS) has been widely utilized for
From the *Departments of Imaging and Medicine and the Burns and Allen
esearch Institute, Cedars-Sinai Medical Center, Los Angeles, California, †Depart-
ent of Medicine, David Geffen School of Medicine, University of California, Los
ngeles, California; ‡Heart Disease Prevention Program, University of California,
rvine, California; and the §Division of Cardiology, Keck School of Medicine,
niversity of Southern California, Los Angeles, California. This study was supported
y a grant from the Eisner Foundation, Los Angeles, California. Dr. John J.
ahamarian acted as Guest Editor for this paper.
Manuscript received January 15, 2004; revised manuscript received June 14, 2004,occepted June 15, 2004.etecting CAD in patients with an intermediate likelihood
f this condition, and for nearly as long it has been established
s highly effective for risk stratification of patients with an
ntermediate or high likelihood of CAD (11–19). Thus, stress
PS is now commonly used for shaping key clinical manage-
ent decisions among patients with suspected or known
AD, such as distinguishing which CAD patients are likely to
enefit from coronary revascularization versus medical man-
gement (20). The wide use and ubiquitous presence of
oninvasive stress tests, such as MPS, coupled with the
ncreasingly recognized utility and growing availability of CAC
canning, raises a new clinical problem for clinicians: how
hould CAC scanning be integrated with conventional stress
maging tests into the clinical assessment of patients with
uspected and known CAD? Understanding the potential
redictive relationship between CAC levels and the likelihood
f stress-induced myocardial ischemia would be central to
ddressing this question. Thus, we undertook the present study
o examine the potential inter-relationship between the pres-
nce and magnitude of CAC and the presence and magnitude
f inducible myocardial ischemia during stress MPS.
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e evaluated 1,195 patients who underwent rest/stress dual
sotope MPS and CAC scanning by EBCT (Imatron
-150 or GE e-Speed, GE-Imatron Inc., South San
rancisco, California) or MSCT (Siemens Volume Zoom,
iemens Medical Systems, Forchheim, Germany) at
edars-Sinai Medical Center within six months of each
ther (7.2  44.8 days). The mean age of the study
opulation was 58.4  10.3 years, and 869 (72.7 %) of the
atients were male. Patients underwent MPS on a clinical
asis, and CAC imaging was performed either on a basis of
elf-referral (n  94 patients), physician-referral (n  777
atients), or ongoing research (n  324 patients) in the
arly Identification of Subclinical Atherosclerosis by Non-
nvasive Imaging Research (EISNER) study. Exclusion
riteria included prior coronary bypass surgery or percuta-
eous coronary intervention, history of myocardial infarc-
ion, known valvular heart disease, or primary cardiomyop-
thy. This research was approved by the Cedars-Sinai
edical Center Institutional Review Board.
maging and stress protocol. Patients were injected intra-
enously at rest with thallium-201 (Tl-201) (3.0 to 4.5
Ci) with dose variation based on patient weight. Rest
l-201 SPECT was initiated 10 min after injection of the
adionuclide (21).
xercise MPS protocol. Following rest MPS, symptom-
imited Bruce protocol treadmill exercise testing was per-
ormed in 1,049 (88%) of the 1,195 study subjects. Exercise
nd-points included physical exhaustion, severe angina,
ustained ventricular tachycardia, hemodynamically signifi-
ant supraventricular dysrhythmias, or exertional hypoten-
ion. In accordance with our policy to discontinue anti-
schemic medications before exercise testing, only 36
ubjects (3.0%) were on beta-blocking medication 48 h,
0 (0.8%) were on calcium blockers 24 h, and 3 (0.3%)
ere on nitrates 6 h before MPS. At near-maximal
xercise, technetium-99m (Tc-99m) sestamibi (25 to 40
Ci) was injected (actual patient dose varied with patient
eight) and exercise continued for an additional 1 min after
Abbreviations and Acronyms
CAC  coronary artery calcium
CAD  coronary artery disease
CT  computed tomography
EBCT  electron beam computed tomography
HU  Hounsfield units
MPS  myocardial perfusion single-photon emission
computed tomography
MSCT  multislice spiral computed tomography
SDS  summed difference score
SPECT  single-photon emission computed tomography
SRS  summed rest score
SSS  summed stress score
Tc  technetium
Tl  thalliumnjection at peak workload, and an additional 1 to 2 min at Meduced workload. Tc-99m sestamibi MPS imaging was
egun 15 to 30 min after radioisotope injection (21).
denosine MPS protocol. In 146 (12%) of the study
ubjects, adenosine stress was performed (22). Patients were
nstructed not to consume caffeine products for 24 h before
PS. Following rest MPS, adenosine was infused (140
g/kg/min for 5 to 6 min), and Tc-99m sestamibi was
njected at the end of the 2nd or 3rd min of infusion for the
- and 6-min infusions, respectively. In patients who could
olerate it, low-level treadmill exercise, as an adjunct to
denosine infusion, was performed at 0% to 10% grade, at 1
o 1.7 miles/h. The Tc-99m sestamibi MPS was initiated
pproximately 60 min after the end of adenosine infusion in
atients who did not exercise and 15 to 60 min after
njection in those with adjunctive exercise.
During both types of stress, blood pressure was recorded
t rest, at the end of each stress stage, and at peak stress.
aximal ST-segment change was assessed as horizontal,
psloping, or downsloping, and electrocardiographic ischemia
as defined as ST-segments 1 mm horizontal or downslop-
ng or 1.5 mm upsloping at 80 ms after the J point.
PECT acquisition protocol. The MPS studies were
erformed on multidetector scintillation cameras using an
lliptical 180° acquisition for 60 to 64 projections at 20 s per
rojection (21). For Tl-201, two energy windows were used,
ncluding a 30% window centered on the 68- to 80-keV
eak and a 10% window centered on the 167 keV peak. For
c-99m sestamibi, a 15% window centered on the 140-keV
eak was used, and images were obtained in both supine and
rone positions. For supine rest and stress MPS studies, gated
PECT was performed, obtaining 8 to 16 frames/cycle.
mages were acquired using a 64  64 image matrix and were
ubject to quality control measures as previously described (21).
o attenuation or scatter correction was employed.
nterpretation of SPECT. Semiquantitative visual interpre-
ation was performed using 20 segments for each image set.
egments were scored by consensus of two experienced ob-
ervers using a 5-point score (0 normal, 1 equivocal, 2
oderate, 3  severe reduction of radioisotope uptake, and 4
absence of detectable tracer uptake in a segment) (21).
cintigraphic indices. The summed stress score (SSS) and
ummed rest score (SRS) were obtained by adding the
cores of the 20 segments of the respective images (19). An
SS 4 was considered abnormal (21). The sum of the
ifferences between each of the 20 segments from these
mages was defined as the summed difference score (SDS),
ncorporating assessment of both the extent and severity of
tress-induced myocardial ischemia, each of which indepen-
ently adds prognostic information (11). The SDS was
onverted to percent myocardium ischemic by dividing the
DS by 80—maximum potential score (4  20)—and
ultiplying by 100. Ischemic and moderate-to-severe isch-
mic MPS studies were defined by 5% and 10% of the
yocardium, respectively (20). Because the presence and
agnitude of hypoperfusion induced during adenosine
PS is roughly equivalent to the magnitude of ischemia
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August 18, 2004:923–30 MPS and EBCTnduced during maximal exercise (23–27), we employ the
erm “inducible ischemia” to represent both the ischemia
uring exercise and adenosine MPS, even though stress
ctual ischemia is often not produced by the adenosine.
alcium scanning. The imaging protocol involved acquir-
ng a single scan on each patient, consisting of approxi-
ately 30 to 40 3- or 2.5-mm slices for EBCT and MSCT
espectively, sufficient to cover the entire heart, with trig-
ering at 50% to 80% of the cardiac cycle. Breath-holding
nstructions were given to minimize misregistration.
ALCIUM SCAN INTERPRETATION. Foci of CAC were iden-
ified by an experienced radiographic technologist and
cored using semiautomatic commercial software on a
etraMD workstation (ScImage, Los Altos, California) by
etection of at least three contiguous pixels (voxel size 
.03 mm3) of peak density 130 Hounsfield units (HU)
ithin a coronary artery. Scoring was performed and verified
y an experienced imaging cardiologist. The software cal-
ulated lesion-specific scores as the product of the area of
ach calcified focus and peak CT number (scored as 1 if 131
o 199 HU, 2 if 200 to 299 HU, 3 if 300 to 399 HU, and
if 400 HU or greater) according to the Agatston method
28). These were summed across all lesions identified within
eft main, left anterior descending, left circumflex, and right
oronary arteries to provide arterial-specific calcium scores,
nd across arteries to provide the total CAC score that was
sed as the principal EBCT/CT measurements in this study.
he CAC percentile score based on age and gender was
ssigned based on cut points from a large database of Raggi et
l. (4) programmed into the ScImage calcium scoring software.
istorical and other clinical variables. Each patient was
uestioned regarding the following: chest symptoms, di-
ided into four chest pain categories (asymptomatic, non-
nginal chest pain, atypical, and typical angina) (29); the
resence or absence of shortness of breath; medication use; and
he following historical coronary risk factors: 1) family history
f early coronary heart disease (male primary relative55 years
f age, female 65 years of age); 2) diabetes; 3) hypertension;
) high serum cholesterol level; and 5) current or past usage of
igarettes. Weight and height were measured with body mass
ndex calculated as weight (kg)/height m2. Bayesian analyses of
atient age, gender, symptoms, risk factors, and, in the exercise
ohort, exercise electrocardiography results were used to calcu-
ate the pre-MPS likelihood of CAD according to a computer
rogram (CADENZA) (30).
tatistical analyses. Total calcium scores were classified
nto six categories: 0 (calcium absent); 1 to 9 (minimal); 10
o 99; 100 to 399; 400 to 999; and 1,000 (5). When being
nalyzed as a continuous variable, a log transform of CAC
as used to reduce the amount of skew of CAC scores and
llow for multivariable statistical analyses that are based on
he assumption of normality. The prevalences of an isch-
mic and moderate to severe ischemic MPS were compared
cross calcium score categories using the chi-square test of
rend. These analyses were also run with stratification by
ender and by presence of symptoms to examine whetherelationships between CAC score category and likelihood of
n ischemic MPS differed by these factors. Analyses were
onducted similarly across CAC score age- and gender-
djusted percentile levels (0 to 24th, 25th to 49th, 50th to
4th, 75th to 89th, and 90th to 99th).
Moreover, among each of these percentile categories, the
elation of CAC score category with MPS result was also
ssessed. The non-parametric Wilcoxon rank sum test for
roportional variables and the Pearson chi-square test of
ssociation for categorical variables were used to compare
ubjects with an abnormal versus normal SPECT result. In
ddition, the Fisher exact test was employed when appro-
riate. Multiple logistic regression was performed to exam-
ne whether log (CAC score 1) was independently asso-
iated with the likelihood of an abnormal MPS result, after
djustment for standardized age, gender, presence of symp-
oms, other clinical characteristics, and CAD risk factors.
he number of days between tests was included to control
or the progression of CAD that might occur during the up
o six-month interval between tests. Receiver operating
haracteristic (ROC) analysis was used to compare the
nformation in predicting ischemic MPS based on age and
ender; age, gender, and symptoms; and the combination of
hese with the CAC score. All continuous variables are
xpressed as mean  SD.
ESULTS
ertinent clinical characteristics for our study population,
tratified by MPS result are shown in Table 1. Of 79
atients with an abnormal MPS, 76 (96%) also had 5%
schemia. The remaining 3 with abnormal MPS had SSS 
but 5% ischemia and were combined with the other
,116 patients with normal MPS to constitute our normal
PS group. Compared to the patients with a normal MPS,
atients with an ischemic study had a more abnormal
oronary risk profile (being significantly older, with more
ales, more hypertension, and a higher mean pre-test
ikelihood of CAD) and significantly greater functional test
bnormalities, including more exercise-induced chest pain,
horter exercise duration, more exercise-induced ST-
egment depression, and a lower mean peak exercise heart
ate. In addition, the ischemic MPS patient group mani-
ested a significantly higher mean CAC score value versus
he normal MPS patient group.
omparison of MPS and CAC scanning. Figure 1 illus-
rates both the frequency of an ischemic MPS and a
oderate to severe ischemic MPS, according to the absolute
AC score, grouped into six categories. Below a calcium
core of 100, the frequency of an ischemic MPS was very
ow (2% overall). At the other end of the spectrum, among
atients with calcium scores 1,000, one-fifth had an
schemic MPS, with less than one-half of these studies
8.6% of all patients with CAC score 1,000) demonstrat-
ng moderate to severe MPS ischemia.Comparison of the SDS by MPS versus log-transformed
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MPS and EBCT August 18, 2004:923–30AC scores revealed a significant but only fair Spearman
orrelation (r  0.195, p  0.05). This relationship was
argely governed by a wide distribution of CAC scores
mong patients with normal MPS, as illustrated in Figure 2.
f patients with ischemic MPS (5% ischemia), 88% had
AC scores  100. Importantly, 56% of the patients with
ormal MPS also had CAC scores 100.
ssessment according to CAC percentile score. Because
oth age and gender are known to impact CAC, we
xamined the relationship between the age-gender percen-
ile CAC score and the frequency of an ischemic MPS (Fig.
). As with the absolute CAC score, a significant overall
rend existed for the frequency of MPS ischemia across
Table 1. Characteristics of the Study Populatio
Parameter
Overall
(n  1,195)
Age, yrs 58.4  10.3
Female 326 (27.3%)
Symptom class
Asymtomatic 609 (51.0%)
Asymptomatic/SOB 658 (55.1%)
Non-anginal pain 112 (9.4%)
Atypical angina 380 (31.8%)
Typical angina 45 (3.8%)
Risk factors
High cholesterol 897 (75.1%)
Hypertension 514 (43.0%)
Family history 448 (37.5%)
Diabetes 138 (11.6%)
Smoking 84 (7.0%)
BMI 26.9  4.8
CAC score 438.9  703.4
Pre-rest likelihood of CAD (%) 24.4 24.1
Exercise stress test* n  1,049
Ischemic stress ECG 220 (21.0%)
Exercise time 9.3  2.7
Exercise chest pain 83 (7.9%)
Rest HR 68.2  12.2
Peak HR 154.3  14.8
Rest SBP 136.7  18.6
Peak SBP 171.6  20.7
Rest DBP 80.4  9.3
Peak DBP 77.2  9.7
*Adenosine stress excluded.
BMI  body mass index; CAC  coronary artery calci
myocardial perfusion single-photon emission computed tomo
igure 1. The frequency of an ischemic myocardial perfusion single-
hoton emission computed tomography (5% ischemic) (gray bars) and of
moderate to severe ischemia (10% ischemic) (black bars) for patients
ivided into six coronary artery calcium (CAC) score groupings. iAC percentile groupings (p 0.0005). For patients below
he 50th percentile of CAC abnormality, the frequency of an
schemic MPS study was very low (2%). Once patients
eached the 50th percentile, the frequency of ischemic MPS
as substantially increased, but it did not vary substantially
mong 50th to 74th, 75th to 89th, and 90th percentile
roups.
Figure 4 demonstrates the frequency of an ischemic MPS
s a function of both the absolute CAC score and the CAC
core (for all values above a 50th percentile CAC ranking).
or each of the shown CAC percentile groups, there was a
ormal MPS
(n  1,119)*
Ischemic MPS
(n  76) p Values
58.1  10.2 61.9  11.1 0.0028
318 (28.4%) 8 (10.5%) 0.001
572 (51.1%) 37 (48.7%) 0.681
621 (55.5%) 37 (48.7%) 0.248
108 (9.7%) 4 (5.3%) 0.204
359 (32.1%) 21 (27.6%) 0.420
31 (2.8%) 14 (18.4%) 0.0001
844 (75.4%) 53 (69.7%) 0.267
465 (41.6%) 49 (64.5%) 0.0001
414 (37.0%) 34 (44.7%) 0.177
126 (11.3%) 12 (15.8%) 0.232
78 (7.0%) 6 (7.9%) 0.760
26.8  4.7 27.9  5.2 0.1028
88.9  617.0 1,175.0  1,272.0 0.0001
23.6  23.1 36.6  33.6 0.0019
n  989 n  58
184 (18.6%) 36 (62.1%) 0.0001
9.4  2.7 7.9  2.8 0.0001
62 (6.3%) 21 (36.2%) 0.0001
68.3  12.1 67.7  13.9 0.738
155  14.4 142.1  16.6 0.0001
136.4  18.7 142.1  17.7 0.0209
171.8  20.8 167.8  18.4 0.0910
80.3  9.2 83.3  9.6 0.0250
77.0  9.6 81.0  10.9 0.0017
AD  coronary artery disease; HR  heart rate; MPS 
; SBP systolic blood pressure; SOB shortness of breath.
igure 2. Distribution of coronary artery calcium (CAC) scores for the
,119 patients manifesting a normal myocardial perfusion single-photon
mission computed tomography (MPS) (left) and the 76 patients with ann
N
3
um; Cschemic MPS (right).
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August 18, 2004:923–30 MPS and EBCTtepwise increase in the frequency of an ischemic SPECT
tudy as the absolute CAC level increased from low to high
alues. Patients with a high percentile ranking (owing to
elatively younger age) but low absolute CAC score did not
anifest inducible ischemia during MPS.
he impact of symptoms. Dividing patients on the basis
f presence or absence of symptoms altered the observed
requencies of ischemic MPS studies among patients whose
alcium scores exceeded 10, as demonstrated in Figure 5. As
he absolute CAC score increased, the difference in the
requency of MPS ischemia among symptomatic versus
symptomatic subjects became progressively more pro-
ounced. When the CAC score was high (400), a
ignificantly higher frequency of ischemia occurred in the
ymptomatic than in the asymptomatic group (18.5% vs.
0.4%; p  0.025).
equence of testing. In 37.8%, 15.6%, and 46.5% of
atients the nuclear scan came before, the same day, or after
igure 3. The frequency of an ischemic myocardial perfusion single-
hoton emission computed tomography (MPS) (5% ischemic) (gray
ars) and moderate to severe ischemic MPS (10% ischemic) (black bars)
ccording to five groupings of age-gender adjusted coronary artery calcium
ercentile score.
igure 4. The frequency of an abnormal myocardial perfusion single-
hoton emission computed tomography (MPS) study according to coro-
ary artery calcium (CAC) percent ranking and absolute CAC score
patients with percentile rankings 50% are not shown owing to the very
ow frequency of abnormal MPS studies in such patients). Within each of
hree CAC percentile groups, patients are further divided on the basis of
heir absolute CAC score, condensed into three subgroups: CAC scores of
to 99, 100 to 399, and 400. The first set of numbers below each bar
epresents the absolute CAC score; the second set represents the mean age
SD; and the third set represents the number of patients within each of
he nine subgroups that are illustrated. Note that regardless of percentile
anking, the frequency of an ischemic MPS study was relatively high when
he absolute CAC score was400, and relatively low when the CAC score
as 100. bhe CT scan, respectively. Interaction terms with test order
nd CAC score or category in relation to likelihood of
ositive MPS were nonsignificant (p  0.05), suggesting
here was no association of test order and the relation
etween CAC and likelihood of MPS ischemia.
ultivariate predictors of abnormal MPS result. Multi-
ariable logistic regression analysis revealed that the log
AC score was the most potent predictor of MPS ischemia
n our study (Table 2). Additional significant variables
ncluded gender, the presence of symptoms (i.e., chest pain
nd/or shortness of breath), a history of hypertension and
igh cholesterol, and increased body mass index. To assess
he potential incremental information provided by CAC
canning for predicting MPS ischemia, we performed an
OC analysis in which the clinical variables of age and
ender were first forced into the multivariate prediction of
PS ischemia (Fig. 6). The subsequent addition of coro-
ary risk factors and chest pain symptom information then
ignificantly increased the size of the ROC area over age and
ender from 67% to 74% (incremental p 0.0061). Finally,
he further addition of the CAC score significantly in-
reased the resultant ROC area beyond the previous curve
o 80% (incremental p  0.0051). All three ROC curves
ere highly significant (p  0.0001). Thus, the CAC score
dds incremental information for predicting the likelihood
igure 5. The frequency of an ischemic myocardial perfusion single-
hoton emission computed tomography for each of the six coronary artery
alcium (CAC) score subgroups, further subdivided on the basis of
ymptoms (chest pain and/or shortness of breath) being absent (gray bars)
r present (black bars).
able 2. Multivariate Predictors of a 5% Ischemic Myocardial
erfusion Single-Photon Emission Computed Tomography
Predictor*
Odds
Ratio p Value 95% CI
og CAC 3.36 0.000 2.13–5.29
ge 1.18 0.260 0.88–1.59
ale gender 1.54 0.020 1.07–2.22
istory of high BP 1.41 0.010 1.09–1.82
istory of high cholesterol 0.72 0.009 0.57–0.92
amily history of CAD 1.34 0.026 1.04–1.73
istory of diabetes 0.98 0.829 0.78–1.22
istory of smoking 1.06 0.631 0.84–1.35
MI 1.30 0.049 1.00–1.70
ymptoms 1.40 0.011 1.08–1.81
ays 0.92 0.552 0.70–1.21
P  blood pressure; BMI  body mass index; CAC  coronary artery calcium; CI
confidence interval; CAD  coronary artery disease; Days  number of daysetween tests. *Predictors have been standardized.
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MPS and EBCT August 18, 2004:923–30f MPS ischemia, even after other predictors of MPS
schemia are first considered.
ISCUSSION
ur results indicate that a threshold phenomenon governs
he relationship between the extent of calcified plaque as
easured by the CAC score by X-ray computed tomogra-
hy and the presence of myocardial ischemia, as measured
y stress MPS. When grouped according to calcium score,
oth patients with a relatively low and relatively high
ikelihood of demonstrating an ischemia MPS study could
e identified. Specifically, among the patients with a cal-
ium score 100 in our study, MPS ischemia was rare,
ccurring in 2% of such patients. This low frequency of
schemia with a CAC score 100 was present in patients
ith and without clinical symptoms, although a trend
oward more ischemia in symptomatic patients with scores
0 to 99 was observed. As the CAC score increased in
agnitude above 100, the frequency of myocardial ischemia on
PS increased progressively. Among patients with CAC
cores exceeding 1,000, 20% manifested ischemia by MPS.
Our results further indicate that the likelihood of myo-
ardial ischemia by MPS is more tightly related to the
bsolute CAC score rather than age-gender–stratified CAC
ercentile score. For example, among patients with CAC
core exceeding 400, the frequency of myocardial ischemia
as comparably high over a wide range of percentile
ankings. These data indicate an important distinction.
hereas a low CAC score with a high percentile ranking in
oung patients may be indicative of long-term risk for
eveloping cardiac events (4,6,31), this same score is prob-
bly not predictive of short-term risk, given the finding that
ost such patients have no evidence of ischemia on MPS.
hus, further testing by MPS of patients found to have high
AC percentile but a CAC score100 would not appear to
e needed in most patients. Of additional interest, our
ndings demonstrated that a relatively high proportion of
atients referred for MPS and found to have no MPS
igure 6. Receiver operating characteristic curve analysis showing incre-
ental prognostic value of coronary artery calcium score in predicting
ikelihood of 5% ischemia. CCS  coronary calcium score; CRF 
oronary risk factors; Sx  symptoms.schemia have a CAC score 100, suggesting that assess- lent of atherosclerotic burden by CAC testing may be
seful in assessing of the need for aggressive attempts to
revent coronary events.
rior studies. Despite the apparent overlap by noninvasive
tress tests (11–20) and CAC scanning (1–10) for assessing
utcomes, few investigations have inquired into the inter-
elationship between results of stress imaging and the
resence and magnitude of CAC abnormality. With one
xception, the small number of prior investigations regard-
ng myocardial ischemia and CAC abnormality primarily
ocused on how these indices compared in their ability to
redict angiographic coronary stenoses, without direct com-
arison of CAC to myocardial ischemia per se (32–35).
nly one prior study has specifically focused on the inter-
elationship between the CAC score and myocardial hypo-
erfusion by MPS (36). In that report, He et al. (36) noted
similar threshold phenomenon with almost no observable
yocardial hypoperfusion among patients with a CAC
core 100 and with a marked increase in the frequency of
n abnormal MPS in patients with high CAC values.
ontrasting with the study of He et al. (36), our study
howed a much lower frequency of MPS abnormality
mong patients with CAC scores 400. The CAC mea-
urements, per se, are highly standardized, and the distri-
ution of symptoms and risk factors were not very dissimilar
or these two studies. Accordingly, the observed differences
n the frequency of MPS abnormality among patients with
igh CAC scores were most likely due to either differences
n the interpretative criteria used to assess the MPS results
n the two studies and/or differences in the referral pattern
o MPS testing after CAC scanning. A preliminary study
ssessing the frequency of MPS abnormality among 121
atients with high CAC scores reported a frequency of
PS abnormality that parallels that noted in our study (37).
he impact of clinical symptoms. Most clinical studies
egarding coronary artery CT have looked primarily at
symptomatic subjects. In our study, however, nearly one-
alf of our patients had clinical symptoms, ranging from
atients complaining of shortness of breath to patients
resenting with typical angina. Like the asymptomatic
atients, our symptomatic patients, as a group, had a very
ow frequency of MPS ischemia when the CAC score was
10. But for each higher CAC score subgroup, including
ven patients with a CAC score of 10 to 99, the symptomatic
atients manifested an approximate tripling of the frequency of
PS ischemia compared to patients without clinical symp-
oms. Accordingly, these results suggest that the presence of
linical symptoms is a strong modifier of the relationship
etween CAC scores and the likelihood of inducible ischemia
nce any substantial degree of CAC is present.
ultivariable analysis. The presence of coronary calcium
as the most potent multivariable predictor of myocardial
schemia during MPS. In addition, chest pain, gender, and
ertain coronary risk factors were additional significant
ultivariate predictors of myocardial ischemia. Neverthe-ess, even when all other predictors of SPECT abnormality
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August 18, 2004:923–30 MPS and EBCTere forced into a multivariate model for predicting MPS
schemia, the CAC score still added significant incremental
alue for this prediction. These results thus parallel prior
bservations indicating that CAC imaging is a potent
ncremental predictor for cardiac events, over and above the
nformation provided by other known predictors of coronary
vents and all-cause mortality (5,6,10).
tudy limitations. Most studies involving tomographic
easurements of coronary calcium have been limited pri-
arily to asymptomatic subjects or patients. Various factors
ave accounted for this, including the relative lack of
idespread third-party reimbursement for this procedure,
eading to out-of-pocket payment by largely asymptomatic
atients, and the established practice of direct stress testing
eferral among patients with anginal symptoms. Thus, even
hough one-half our population was symptomatic, the
opulation was heavily skewed toward atypical chest pain
ymptoms and a relatively low likelihood of CAD, averaging
25% CAD likelihood.
Additionally, one-half of the patients were asymptomatic.
lthough all patients in this study were referred for MPS by
heir physicians, it should be noted that there are currently
o class Ia indications for stress MPS in asymptomatic
ndividuals (38). It is possible that some of the inter-
elationships noted in this study, such as the relative
trength of chest pain symptoms to predict myocardial
schemia, would have been affected had we been able to
ncorporate more patients with typical angina into this
tudy. Similarly, our ability to perform subanalyses, such as
he impact of symptoms and gender effects, had limited
tatistical power owing to the relatively low frequency of
PS ischemia in our study. Accordingly, prospective stud-
es that focus on the inter-relationship between MPS
tudies and calcium scores in populations containing more
atients with typical angina and/or inducible myocardial
schemia would be useful for extending our findings.
Finally, as CAC matures as a testing modality in cardi-
logy, it will be interesting to evaluate whether the per-
eived accuracy of this test is subject to patient referral bias,
s has been observed for other noninvasive tests in cardiol-
gy (39).
linical implications. Three broad implications emanate
rom our results. First, they help to define the future
ndications for stress MPS referral after CAC imaging.
pecifically, it appears that the referral of patients for MPS
s generally not needed when the CAC score is100 due to
he very low likelihood of observing inducible myocardial
schemia in such patients. Conversely, when the CAC score
xceeds 400, stress imaging would appear to be generally
eneficial, because the frequency of inducible ischemia is
ubstantial within this CAC range, even in asymptomatic
atients.
Second, our results indicate that CAC scores in the range
f 100 to 400 constitute a relatively large “gray zone” relative
o the issue of who may require stress-test referral following
AC imaging. Pending confirmation, our results suggesthat within this range of CAC scores, clinical factors such as
ymptoms, gender, coronary risk factors, and stress ECG
esults may serve to impact substantially on the observed
requency of MPS ischemia. Accordingly, future studies
nvolving large number of patients with CAC scores in the
ange of 100 to 400 are needed to define the best combi-
ation of clinical predictors for predicting an ischemic MPS
tudy in this CAC score range. In general, however, it
ppears from our data that within this range, any threshold
or referral to MPS testing following CAC scanning should
e lower among symptomatic patients or among those of
ale gender. Conversely, an asymptomatic presentation is
ikely to be associated with a higher recommended CAC
hreshold value before referral for stress testing becomes
ost-effective after CAC scanning.
One potential approach to determining whether MPS
ould be of value in a given patient might be to combine the
AC score with all other relevant clinical and historical
nformation into a Bayesian estimate of likelihood for
ngiographically significant CAD, as suggested by a recent
tudy (39). However, more work is needed to validate this
pproach and compare it with other potential approaches
or integrating the results of CAC scanning into clinical
ractice, such as the use of the Framingham risk score in
symptomatic patients.
Third, the wide range of CAC scores in our patients with
ormal MPS studies exposes an important limitation rele-
ant to all forms of stress testing: they do not effectively
creen for subclinical atherosclerosis. For instance, only 22%
f our patients with a normal SPECT study had no evidence
f CAC, 56% had a CAC score100, and 31% had a CAC
core 400. Further, even among those with CAC scores
1,000, 85% of asymptomatic and nearly 68% of symptom-
tic patients had a normal MPS study.
Along these lines, there are yet no available data to
ompare the relative short and long-term risk for cardiac
vents among patients with various combinations of MPS
esults and CAC scores, such as those presenting with the
ombination of very high CAC scores but normal MPS
esults. It is reasonable to hypothesize that such patients
ight be at low short-term risk but high long-term risk for
ardiac events. If so, CAC could then be unmasking a
ubgroup of patients who would receive more aggressive
nti-atherosclerotic intervention than would have been in-
icated based on the results of MPS testing alone. Accord-
ngly, future studies incorporating the prognostic follow-up
ata from patients undergoing both studies would now be of
nterest, so as to determine which patients with normal
tress imaging tests are best suited for undergoing subsequent
AC scanning.
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